(Q45274597)

11 December 2017

title

Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). (English)

1 reference

11 December 2017

1 reference

4

Mathuram Santosham

1 reference

11 December 2017

Timo Vesikari

1

1 reference

11 December 2017

Robbin Itzler

2

1 reference

11 December 2017

David O Matson

3

1 reference

11 December 2017

Celia D C Christie

5

1 reference

11 December 2017

Michele Coia

6

1 reference

11 December 2017

John R Cook

7

1 reference

11 December 2017

Gary Koch

8

1 reference

11 December 2017

Penny Heaton

9

1 reference

11 December 2017

publication date

1 November 2007

1 reference

International Journal of Infectious Diseases

11 December 2017

published in

1 reference

11 December 2017

volume

11 Suppl 2

1 reference

11 December 2017

page(s)

S29-35

1 reference

Rotavirus vaccines: past, present, and future

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

Rotavirus infection in infants as protection against subsequent infections

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

Rotavirus vaccines against diarrhoeal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

Models for longitudinal data: a generalized estimating equation approach

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

Safety evaluation and confidence intervals when the number of observed events is small or zero

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

Comparative practice patterns of emergency medicine physicians and pediatric emergency medicine physicians managing fever in young children

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

Burden of rotavirus disease in European Union countries

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

Rotavirus gastroenteritis in Finland: burden of disease and epidemiological features.

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS1201-9712%2807%2960019-8

7 January 2021

10.1016/S1201-9712(07)60019-8

Identifiers

DOI

1 reference

11 December 2017

1 reference